Top Markets
Coin of the day
Gelesis Holdings, Inc. Gelesis Holdings, Inc.

Gelesis Holdings, Inc.

GLS
株式のランク #40696
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
株価
$0.0121
最終同期: 2023-05-23
時価総額
$97.54K
変化(1日)
-24.38%
変化(1年)
0.00%
US
取引 Gelesis Holdings, Inc. (GLS)

カテゴリー

Gelesis Holdings, Inc.(GLS)の株式分割履歴
Gelesis Holdings, Inc.株(シンボル:GLS)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 13, 2026に行われました。
Aug 13, 2026より前に購入されたGLS株は、現在0GLS株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE